Fighting Falsified Medicines with Paperwork – A Historic Review of Danish Legislation Governing Distribution of Medicines

Research output: Contribution to journalJournal articleResearchpeer-review

Many areas of pharmaceutical legislation in the European Union (EU) are harmonised in order to promote the internal market and protect public health. Ideally, harmonisation leads to less fragmented regulation and cross-border complexities. This study, however, focuses on an increasingly harmonised legislative area that is subject to increases in requirements and complexities: the distribution of medicines. This study compared Danish legislation governing the distribution of medicines before and after Denmark joined the EU in order to assess the impact of EU harmonisation, as well as to evaluate whether the drastic increases in requirements mandated by the Falsified Medicines Directive of 2011 correspond to a new approach to governing the pharmaceutical supply chain.


Original languageEnglish
JournalJournal of Pharmaceutical Policy and Practice
Volume30
Issue number9
Pages (from-to)1-8
Number of pages8
ISSN2052-3211
DOIs
Publication statusPublished - 6 Oct 2016

    Research areas

  • The Faculty of Law - Pharmaceutical policy, risk management, regulation, legislation, Europe, , Falsified Medicines Directive

ID: 141957728